81 related articles for article (PubMed ID: 8482142)
1. [DNA analysis in stomach cancer--correlation of aneuploidy with tumor site].
Jähne J; Urmacher C; Cordon-Cardo C; Meyer HJ; Pichlmayr R
Chirurg; 1993 Apr; 64(4):275-8. PubMed ID: 8482142
[TBL] [Abstract][Full Text] [Related]
2. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
[TBL] [Abstract][Full Text] [Related]
3. Is DNA aneuploidy a prognostic factor in gastric cancer?
Omejc M; Repse S; Bracko M
Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
6. DNA mapping of gastric cancers using flow cytometric analysis.
Sugai T; Uesugi N; Habano W; Nakamura S; Suto T; Fujimaki E; Itoh C
Cytometry; 2000 Oct; 42(5):270-6. PubMed ID: 11025484
[TBL] [Abstract][Full Text] [Related]
7. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
Wang Z; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
11. [Fluorocytometric DNA analysis of intestinal metaplasia associated with gastric carcinoma].
Oshiro T; Baba H; Okuyama T; Inutsuka S; Takeuchi H; Adachi Y; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1993 Apr; 20(6):709-12. PubMed ID: 8489271
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy heterogeneity in early and advanced gastric cancers.
Fujimaki E; Sasaki K; Nakano O; Chiba S; Tazawa H; Yamashiki H; Orii S; Sugai T
Cytometry; 1996 Jun; 26(2):131-6. PubMed ID: 8817089
[TBL] [Abstract][Full Text] [Related]
13. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of gastric cancer that is invading the muscularis propria.
Mizunuma H; Tsuchiya A; Ando Y; Kikuchi Y; Abe R
Eur J Surg; 1996 Nov; 162(11):889-94. PubMed ID: 8956958
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Gasiorowski L; Kaczmarek E
Lung Cancer; 2006 Feb; 51(2):201-6. PubMed ID: 16375987
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
17. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
[TBL] [Abstract][Full Text] [Related]
18. [DNA content and survival in subserous gallbladder carcinoma].
Roa I; de Aretxabala X; Fuentealba P; Cabrera ME; Araya JC; Roa J
Rev Med Chil; 2004 Jul; 132(7):794-800. PubMed ID: 15379325
[TBL] [Abstract][Full Text] [Related]
19. Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions.
Teodori L; Capurso L; Cordelli E; De Vita R; Koch M; Tarquini M; Pallone F; Mauro F
Cytometry; 1984 Jan; 5(1):63-70. PubMed ID: 6697823
[TBL] [Abstract][Full Text] [Related]
20. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]